Gene · 11065
Papers2,651
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,651
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Whole transcriptome scanning and validation of negatively related genes in UC-MSCs. | Heliyon | 2024 | 38510024 | PubTator, text mining | PubMed |
| DeepCBS: shedding light on the impact of mutations occurring at CTCF binding sites. | Front Genet | 2024 | 38463168 | PubTator, text mining | PubMed |
| Integrative single-cell transcriptomic analyses reveal the cellular ontological and functional heterogeneities of primary and metastatic liver tumors. | J Transl Med | 2024 | 38414027 | PubTator, text mining | PubMed |
| Prognostic implication of UBE2C + CD8 + T cell in neoadjuvant immune checkpoint blockade plus chemotherapy for locally advanced esophageal cancer. | Int Immunopharmacol | 2024 | 38412672 | PubTator, text mining | PubMed |
| UBE2C is a diagnosis and therapeutic biomarker involved in immune infiltration of cancers including lung adenocarcinoma. | J Cancer | 2024 | 38370368 | PubTator, text mining | PubMed |
| Curcumin inhibits prostate cancer by upregulating miR-483-3p and inhibiting UBE2C. | J Biochem Mol Toxicol | 2024 | 38348716 | PubTator, text mining | PubMed |
| Construction of immune-related molecular diagnostic and predictive models of hepatocellular carcinoma based on machine learning. | Heliyon | 2024 | 38312556 | PubTator, text mining | PubMed |
| Identification and preliminary analysis of hub genes associated with bladder cancer progression by comprehensive bioinformatics analysis. | Sci Rep | 2024 | 38307969 | PubTator, text mining | PubMed |
| MiR-4492, a New Potential MicroRNA for Cancer Diagnosis and Treatment: A Mini Review. | Chonnam Med J | 2024 | 38304137 | PubTator, text mining | PubMed |
| mvlearnR and Shiny App for multiview learning. | Bioinform Adv | 2024 | 38304121 | PubTator, text mining | PubMed |
| Special Issue: "Drug Repurposing for Cancer Therapies". | Int J Mol Sci | 2024 | 38256165 | PubTator, text mining | PubMed |
| Establishment and Validation of Novel Prognostic Subtypes in Hepatocellular Carcinoma Based on Bile Acid Metabolism Gene Signatures Using Bulk and Single-Cell RNA-Seq Data. | Int J Mol Sci | 2024 | 38255993 | PubTator, text mining | PubMed |
| Sox9 regulates alternative splicing and pancreatic beta cell function. | Nat Commun | 2024 | 38238288 | PubTator, text mining | PubMed |
| PRADclass: Hybrid Gleason Grade-Informed Computational Strategy Identifies Consensus Biomarker Features Predictive of Aggressive Prostate Adenocarcinoma. | Technol Cancer Res Treat | 2024 | 38226611 | PubTator, text mining | PubMed |
| Human iPSC modeling recapitulates in vivo sympathoadrenal development and reveals an aberrant developmental subpopulation in familial neuroblastoma. | iScience | 2024 | 38222111 | PubTator, text mining | PubMed |
| Paneth-like cells produced from OLFM4+ stem cells support OLFM4+ stem cell growth in advanced colorectal cancer. | Commun Biol | 2024 | 38182890 | PubTator, text mining | PubMed |
| Single-cell transcriptomics enable the characterization of local extension in retinoblastoma. | Commun Biol | 2024 | 38172218 | PubTator, text mining | PubMed |
| Advanced esophageal cancer with bone metastases: Prognostic biomarkers and palliative treatment. | Heliyon | 2024 | 38170113 | PubTator, text mining | PubMed |
| Feeder-free generation and characterization of endocardial and cardiac valve cells from human pluripotent stem cells. | iScience | 2024 | 38170020 | PubTator, text mining | PubMed |
| Exploring the Potential of Rosemary Derived Compounds (Rosmarinic and Carnosic Acids) as Cancer Therapeutics: Current Knowledge and Future Perspectives. | Biomol Ther (Seoul) | 2024 | 38148552 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11065/papers?page=10